Breathing Circuits Market size is set to log expansive growth between 2023 and 2032, on account of the growing burden of chronic respiratory conditions like asthma and COPD, among others. According to estimates from the Centers for Disease Control and Prevention (CDC), almost 25 million Americans suffer from asthma, affecting 7% of children and 8% of adults.
Breathing circuits are an assembly of components designed to create a connection between the anesthesia machine and the patient’s airway, developing an artificial environment into and from which the patient breathes. The development of non-invasive ventilation techniques and high-flow oxygen therapy for the treatment of such respiratory illnesses could boost the demand for breathing circuit systems in the years ahead.
Based on product type, the closed breathing circuits industry is set to register commendable gains by 2032. Closed breathing systems, such as the circle system, are one of the popular breathing circuits in the U.S. The equipment is used to chemically cleanse CO2 from the exhalations, thereby allowing them to breathe other exhaled gases, and elucidating key benefits such as the ability to conserve respiratory heat and humidity.
According to the regional outlook, Europe is forecasted to emerge as a key avenue for the breathing circuits market, due to the rising disease burden in the region. Various authorities and entities are creating comprehensive respiratory care programs which could spike the expansion for breathing systems.
The major players operating in the global breathing circuits industry market include Armstrong Medical Ltd, WilMarc Medical Teleflex Incorporated, Altera, GE Healthcare, Becton, C. R. Bard (Becton, Dickinson and Company), Dickinson and Company, and Bio-Med Devices. These players are involved in several business strategies such as new product launches and collaborations to maintain presence in the global business landscape.
Advancements in Breathing Circuits Market Trends
A surge in medical conditions, particularly respiratory illnesses, worldwide could amplify the value for new breathing circuits in the years to come. Acute respiratory distress syndrome or ARDS is observed among several patients which have led to an increase in outlook for mechanical ventilation and intubation. Health organizations like the WHO and U.S. FDA have issued guidelines to facilitate the production, approval and adoption of new ventilation systems.
As healthcare systems across the world deal with an overwhelming number of patient admissions to ICUs and hospitals, companies specializing in breathing circuits could potentially harness significant product demand. Furthermore, new research activities targeted toward the upgradation of breathing circuits could present lucrative revenue opportunities to the breathing circuits market during the forecast period.